Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Lynette Cederquist et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1.4K citations · Full text

Medicine, Molecular Medicine, Oncology +17

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 633 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Molecular Diagnostics · 2018 · 352 citations · Full text

Medicine, Molecular Medicine, Oncology +16

NCCN Guidelines Insights: Melanoma, Version 3.2016

Daniel G. Coit, John A. Thompson, Alain P. Algazi et al. · Journal of the National Comprehensive Cancer Network · 2016 · 100 citations

Medicine, Oncology, Chemotherapy +16

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform

Arja ter Elst, Lisette J. Bosman, Inge Platteel et al. · Melanoma Research · 2017 · 55 citations · Full text

Medicine, Oncology, Pathology +17